AmberHealth logo

AmberHealth Review

7.7
★★★★☆3.9/5
No longer sells GLP-1s: the brand now sells only an over-the-counter supplement

AmberHealth is no longer available as we reviewed it, so this page is kept for reference.

AmberHealth: No longer sells GLP-1s: the brand now sells only an over-the-counter supplement. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

AmberHealth ran a compounded GLP-1 telehealth program until mid-2026. That program has been retired: the domain now sells a single over-the-counter supplement and offers no prescription service.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Supplement (no prescription)Single-product storeProgram retired 2026

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to AmberHealth

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
AmberHealth logo
3.9 / 5
Our editorial rating

AmberHealth at a glance

Type
GLP-1 telehealth provider
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored AmberHealth

Each dimension is scored algorithmically from AmberHealth’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.3/10

AmberHealth no longer sells GLP-1 treatment, so no current price applies.

Effectiveness25%

6.7/10

AmberHealth's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence, so weigh the clinical support carefully.

User Experience15%

8.1/10

Online intake and platform experience; 3 platform features disclosed.

Trust & Safety15%

9.0/10

Key details fully confirmed by our editors; no FDA warning letters on file.

Accessibility10%

9.5/10

AmberHealth treats patients in all 50 states.

Support10%

7.1/10

AmberHealth provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this AmberHealth review

Last checked August 2026
  • Confirmed availability in all 50 states
  • Checked the FDA warning-letter database for enforcement actions

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

FDA warning-letter register
No letter on file for this provider

What we like

  • Review page kept live so former patients get a straight answer

Watch-outs

  • GLP-1 telehealth program retired, so no prescriptions are available
  • No published route to reach a prescriber or transfer records
  • Remaining product is an unprescribed supplement, not a GLP-1

AmberHealth no longer prescribes GLP-1s, and the name now sells a supplement

If you came here looking for AmberHealth's compounded GLP-1 program, it is gone. Through at least early June 2026 AmberHealth's website ran a prescription telehealth service: compounded semaglutide and tirzepatide, each with B12, at a flat monthly rate that did not rise as your dose climbed. By August 2026, every part of that program had been removed. What sits at the same address today is a single-product e-commerce store selling an over-the-counter capsule marketed as "GLP-1 Natural Support." It is not a GLP-1 medication, it is not prescribed, and no clinician is involved in selling it to you.

The change runs deeper than a page that failed to load. The store's own site map lists seven pages in total: the homepage, a contact page, a data-sharing opt-out, a blog, a collection, an agents file, and one product. Its full catalog is that same single product. The terms of service, just over four thousand characters long, never once use the words prescription, pharmacy, clinician or telehealth, which a company practicing medicine could not leave out of its own terms.

What that means if you were a patient

There is no published route to refill a prescription, reach a prescriber, or retrieve your records through the site as it now stands. The only contact channel is a support email address for the store. If you were mid-treatment, the practical priority is getting your prescription and clinical notes transferred somewhere that can continue your care. A GLP-1 is not a medication to stop abruptly without a plan, and dose continuity matters. Ask your new provider to request records directly, and if you have a pharmacy name on a previous label, contact that pharmacy too, because the dispensing pharmacy is a separate business from the platform that arranged the visit.

The supplement is not a substitute, and shouldn't be read as one

Products named to evoke GLP-1s are a well-established category of their own, and the naming does a lot of work. A capsule sold without a prescription is a dietary supplement: it is not reviewed by the FDA for effectiveness before sale, it is not the same class of thing as semaglutide or tirzepatide, and it should not be expected to do what those drugs do. Whatever the merits of this particular product, swapping a prescription GLP-1 for it is a change in kind, not a change in brand. WLR ranks prescription providers, so a supplement store falls outside what this page was built to compare, which is why AmberHealth no longer appears on any of our rankings or best-of lists.

Where to look instead

If flat-rate pricing was the reason AmberHealth appealed to you, search for that model by name. A rate that stays fixed through titration rather than climbing at every dose step is still offered by a number of active providers. It is the single feature that most changes what a course of treatment costs. The alternatives listed on this page are all currently operating and carry current prices. Compare what each one bundles as well as what it charges: a low headline number that excludes the consult, the shipping or the dose increase is not the cheaper option it appears to be. Our scoring methodology explains how we weigh those inclusions.

Bottom line

AmberHealth's GLP-1 telehealth program has been retired, and the brand now operates as a single-SKU supplement store. We have kept this page up because "is AmberHealth still around?" is a reasonable thing to search for and deserves a straight answer rather than a dead link. The answer is that the company still exists, the prescription service does not, and the product now sold under the name is a different thing entirely.

The Bottom Line

AmberHealth is no longer available as we reviewed it, so this page is kept for reference.

Score: 7.7/10Best for: readers checking whether it still operates

AmberHealth might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Frequently Asked Questions

The company still exists, but its GLP-1 telehealth program does not. As of 16 August 2026 AmberHealth's website sells one over-the-counter supplement and offers no prescription service. Its published sitemap lists seven URLs in total and its catalog holds a single product, so this is a change to the whole business rather than a page that happened to be down.
A single-product e-commerce store. The one item for sale is a capsule marketed as GLP-1 Natural Support, sold without a prescription and with no clinician involved. Until mid-2026 the same domain ran a compounded semaglutide and tirzepatide telehealth service; that service has been retired.
There is no longer a monthly program to price. The prescription rates the site listed as recently as June 2026 (roughly $99 a month for compounded semaglutide and $174 for tirzepatide, both flat across doses) no longer appear anywhere on the site, so they are no longer shown here. The remaining supplement is sold as a one-off purchase at a listed $44.95, discounted from $69.99, with multi-bottle bundles.
No. Neither medication is offered, and there is no intake, consultation or prescribing route published on the site. If you were a patient, arrange to continue care elsewhere rather than stopping abruptly, and ask your new provider to request your records. A GLP-1 dose should be continued or tapered on clinical advice, not interrupted by a provider closing.
No. It is a dietary supplement, which means it is not reviewed by the FDA for effectiveness before it goes on sale and is not the same class of product as semaglutide or tirzepatide. A name that references GLP-1 describes the marketing, not the ingredient. Treating it as a replacement for a prescription GLP-1 is a change in kind, not a change in brand.
Because people still want to know whether a provider is operating, and a straight answer is more useful than a dead link. The page is excluded from every WLR ranking and best-of list, carries no outbound link to the company, and points to currently operating alternatives instead.
AmberHealth is not an option for new weight-loss patients now (no longer sells GLP-1s: the brand now sells only an over-the-counter supplement). We found no FDA warning letter on file for it.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for AmberHealth. The concerns our review flags: GLP-1 telehealth program retired, so no prescriptions are available; No published route to reach a prescriber or transfer records; Remaining product is an unprescribed supplement, not a GLP-1. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this AmberHealth review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.